3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family
- PMID: 17293140
- DOI: 10.1016/j.jmgm.2006.12.001
3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family
Abstract
For targets belonging to the same family of receptors, inhibitors often act at more than one biological target and produce a synergistic effect. Separate CoMFA and CoMSIA models were developed from our data set for the KDR, cKit and Tie-2 inhibitors. These models showed excellent internal predictability and consistency, and validation using test-set compounds yielded a good predictive power for the pIC(50) value. The field contour maps (CoMFA and CoMSIA) corresponding to the KDR, cKit and Tie-2 kinase subtypes reflected the characteristic similarities and differences between these types. These maps provided valuable information to facilitate structural modifications of the inhibitor to increase selectivity for the KDR over cKit and Tie-2.
Similar articles
-
Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking.J Mol Graph Model. 2009 Jan;27(5):642-54. doi: 10.1016/j.jmgm.2008.10.006. Epub 2008 Nov 5. J Mol Graph Model. 2009. PMID: 19081278
-
Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.J Mol Graph Model. 2010 Aug 24;29(1):54-71. doi: 10.1016/j.jmgm.2010.04.004. Epub 2010 Apr 24. J Mol Graph Model. 2010. PMID: 20471293
-
Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.Bioorg Med Chem Lett. 2007 Apr 15;17(8):2126-33. doi: 10.1016/j.bmcl.2007.01.089. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17306530
-
Design strategies for protein kinase inhibitors.Curr Opin Drug Discov Devel. 2004 Sep;7(5):617-29. Curr Opin Drug Discov Devel. 2004. PMID: 15503864 Review.
-
Development and strategies of VEGFR-2/KDR inhibitors.Future Med Chem. 2012 Sep;4(14):1839-52. doi: 10.4155/fmc.12.121. Future Med Chem. 2012. PMID: 23043480 Review.
Cited by
-
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.J Neurooncol. 2013 Jan;111(2):205-12. doi: 10.1007/s11060-012-1009-y. Epub 2012 Nov 27. J Neurooncol. 2013. PMID: 23184145 Clinical Trial.
-
Correction: Xie, H.; et al. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int. J. Mol. Sci. 2014, 15, 20927-20947.Int J Mol Sci. 2015 Mar 5;16(3):5072-5. doi: 10.3390/ijms16035072. Int J Mol Sci. 2015. PMID: 25751723 Free PMC article.
-
Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors.Int J Mol Sci. 2011;12(8):5080-97. doi: 10.3390/ijms12085080. Epub 2011 Aug 10. Int J Mol Sci. 2011. PMID: 21954347 Free PMC article.
-
3D-QSAR study of c-Src kinase inhibitors based on docking.J Mol Model. 2010 Feb;16(2):361-75. doi: 10.1007/s00894-009-0530-1. Epub 2009 Jul 17. J Mol Model. 2010. PMID: 19609579
-
A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.Int J Mol Sci. 2015 May 29;16(6):12307-23. doi: 10.3390/ijms160612307. Int J Mol Sci. 2015. PMID: 26035757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous